Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yiyuan Han, Ph.D.

Concepts (14)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Yiyuan Han's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Yiyuan Han has written about over time.
Analgesics, Opioid, 1 publications between 2023 and 2023, average publication date November 2023. Naloxone, 1 publications between 2023 and 2023, average publication date November 2023. Narcotic Antagonists, 1 publications between 2023 and 2023, average publication date November 2023. Animals, 2 publications between 2023 and 2024, average publication date February 2024. Mice, 2 publications between 2023 and 2024, average publication date February 2024. Polymers, 2 publications between 2023 and 2024, average publication date February 2024. Anesthesia, Local, 1 publications between 2024 and 2024, average publication date June 2024. Anesthetics, Local, 1 publications between 2024 and 2024, average publication date June 2024. Boronic Acids, 1 publications between 2024 and 2024, average publication date June 2024. Drug Delivery Systems, 1 publications between 2024 and 2024, average publication date June 2024. Nanoparticles, 1 publications between 2024 and 2024, average publication date June 2024. Prodrugs, 1 publications between 2024 and 2024, average publication date June 2024. Sciatic Nerve, 1 publications between 2024 and 2024, average publication date June 2024. Tetrodotoxin, 1 publications between 2024 and 2024, average publication date June 2024.

To see the data from this visualization as text, click here.
Han's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (14)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.